
Solu Therapeutics
Developer of bifunctional small-molecule therapeutics designed to eliminate disease-driving cells. The company's platform combines selective small-molecule binders with proprietary antibodies and prov...
Valuation
$104M
Latest known
Share Price
N/A
Total Raised
$72M
Last Round
N/A